Dear friends yesterday was published International guidelines on allergy immunotherapy 2015! Take a look!
Allergen immunotherapy (AIT) has been used to treat allergic disease
since the early 1900s. Despite numerous clinical trials and
meta-analyses proving AIT efficacious, it remains underused and is
estimated to be used in less than 10% of patients with allergic rhinitis
or asthma worldwide. In addition, there are large differences between
regions, which are not only due to socioeconomic status. There is
practically no controversy about the use of AIT in the treatment of
allergic rhinitis and allergic asthma, but for atopic dermatitis or food
allergy, the indications for AIT are not well defined. The elaboration
of a wider consensus is of utmost importance because AIT is the only
treatment that can change the course of allergic disease by preventing
the development of asthma and new allergen sensitizations and by
inducing allergen-specific immune tolerance. Safer and more effective
AIT strategies are being continuously developed both through elaboration
of new allergen preparations and adjuvants and alternate routes of
administration.
A number of guidelines, consensus documents, or both are
available on both the international and national levels. The
international community of allergy specialists recognizes the need to
develop a comprehensive consensus report to harmonize, disseminate, and
implement the best AIT practice. Consequently, the International
Collaboration in Asthma, Allergy and Immunology, formed by the European
Academy of Allergy and Clinical Immunology; the American Academy of
Allergy, Asthma & Immunology; the American College of Allergy,
Asthma & Immunology; and the World Allergy Organization, has decided
to issue an international consensus on AIT.
Free Full text:
http://www.jacionline.org/article/S0091-6749%2815%2900775-7/fulltext?utm_content=buffera3d39&utm_medium=social&utm_source=facebook.com&utm_campaign=buffer
No comments:
Post a Comment